Stromab

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameStromab
Drug Alias NameTS-23DS-9231
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAlpha-2-antiplasmin inhibitors
TargetsAlpha-2-antiplasmin
Therapy Area/IndicationsIschemic StrokeVenous ThrombosisThrombosis +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTranslational Sciences Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsIschemic StrokePulmonary Embolism
Inactive IndicationsVenous ThrombosisThrombosisMyocardial Infarction +[4

Other Information

ATC CodeN/A
Related LinksN/A